SE9801090D0 - New medium and process - Google Patents

New medium and process

Info

Publication number
SE9801090D0
SE9801090D0 SE9801090A SE9801090A SE9801090D0 SE 9801090 D0 SE9801090 D0 SE 9801090D0 SE 9801090 A SE9801090 A SE 9801090A SE 9801090 A SE9801090 A SE 9801090A SE 9801090 D0 SE9801090 D0 SE 9801090D0
Authority
SE
Sweden
Prior art keywords
new medium
nutrient medium
medium
cells
methionine
Prior art date
Application number
SE9801090A
Other languages
English (en)
Other versions
SE519827C2 (sv
SE9801090L (sv
Inventor
Mats Jarekrans
Hans Olovsson
Original Assignee
Bionative Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionative Ab filed Critical Bionative Ab
Priority to SE9801090A priority Critical patent/SE519827C2/sv
Publication of SE9801090D0 publication Critical patent/SE9801090D0/sv
Priority to HU0102319A priority patent/HU225802B1/hu
Priority to AU36331/99A priority patent/AU3633199A/en
Priority to US09/647,402 priority patent/US6309862B1/en
Priority to DK99918400.5T priority patent/DK1073715T3/da
Priority to EP99918400.5A priority patent/EP1073715B1/en
Publication of SE9801090L publication Critical patent/SE9801090L/sv
Publication of SE519827C2 publication Critical patent/SE519827C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9801090A 1998-03-30 1998-03-30 Näringsmedium innehållande metionin samt användning av detta SE519827C2 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9801090A SE519827C2 (sv) 1998-03-30 1998-03-30 Näringsmedium innehållande metionin samt användning av detta
HU0102319A HU225802B1 (en) 1998-03-30 1999-03-23 Methionin containing animal cell culture medium and its use
AU36331/99A AU3633199A (en) 1998-03-30 1999-03-23 Methionin containing animal cell culture medium and its use
US09/647,402 US6309862B1 (en) 1998-03-30 1999-03-23 Methionine containing animal cell culture medium and its use
DK99918400.5T DK1073715T3 (da) 1998-03-30 1999-03-23 Dyrecellekulturmedium, der indeholder methionin, og anvendelse deraf
EP99918400.5A EP1073715B1 (en) 1998-03-30 1999-03-23 Methionin containing animal cell culture medium and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801090A SE519827C2 (sv) 1998-03-30 1998-03-30 Näringsmedium innehållande metionin samt användning av detta

Publications (3)

Publication Number Publication Date
SE9801090D0 true SE9801090D0 (sv) 1998-03-30
SE9801090L SE9801090L (sv) 1999-11-30
SE519827C2 SE519827C2 (sv) 2003-04-15

Family

ID=20410773

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801090A SE519827C2 (sv) 1998-03-30 1998-03-30 Näringsmedium innehållande metionin samt användning av detta

Country Status (6)

Country Link
US (1) US6309862B1 (sv)
EP (1) EP1073715B1 (sv)
AU (1) AU3633199A (sv)
DK (1) DK1073715T3 (sv)
HU (1) HU225802B1 (sv)
SE (1) SE519827C2 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002365162A1 (en) * 2001-11-14 2003-07-09 Northwestern University Self-assembly and mineralization of peptide-amphiphile nanofibers
US7371719B2 (en) * 2002-02-15 2008-05-13 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
US20050272662A1 (en) * 2002-09-23 2005-12-08 Stupp Samuel I Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals
US7554021B2 (en) * 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
WO2004046167A2 (en) * 2002-11-14 2004-06-03 Northwestern University Synthesis and self-assembly of abc triblock bola peptide
ES2380340T3 (es) 2003-12-05 2012-05-10 Northwestern University Anfífilos peptídicos auto-ensamblantes y métodos relacionados para la administración de factores de crecimiento
WO2006079036A2 (en) * 2005-01-21 2006-07-27 Northwestern University Methods and compositions for encapsulation of cells
US7510732B2 (en) * 2005-02-16 2009-03-31 Cambridge Scientific Pty Ltd Analgesic and anti-inflammatory composition
NZ560649A (en) * 2005-03-04 2011-03-31 Univ Northwestern Angiogenic heparin binding peptide amphiphiles, peptide amphiphiles, self-assembled composition and related methods of use
US8076295B2 (en) * 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
US8450271B2 (en) * 2009-04-13 2013-05-28 Northwestern University Peptide-based scaffolds for cartilage regeneration and methods for their use
EP3969564A1 (en) * 2019-05-16 2022-03-23 Formycon AG Method for reducing methionine oxidation in recombinant proteins
US11098311B2 (en) 2019-12-06 2021-08-24 Regeneron Pharmaceuticals, Inc. Anti-VEGF protein compositions and methods for producing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
HU192254B (en) 1983-12-13 1987-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing human leucocite and human gamma interferons in consecutive steps
US5272135A (en) 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
US5676942A (en) 1992-02-10 1997-10-14 Interferon Sciences, Inc. Composition containing human alpha interferon species proteins and method for use thereof
US5358708A (en) 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations

Also Published As

Publication number Publication date
HU225802B1 (en) 2007-09-28
HUP0102319A2 (hu) 2001-10-28
SE519827C2 (sv) 2003-04-15
HUP0102319A3 (en) 2003-03-28
AU3633199A (en) 1999-10-18
SE9801090L (sv) 1999-11-30
EP1073715B1 (en) 2013-06-26
EP1073715A1 (en) 2001-02-07
DK1073715T3 (da) 2013-07-15
US6309862B1 (en) 2001-10-30

Similar Documents

Publication Publication Date Title
SE9801090D0 (sv) New medium and process
EE9700018A (et) Bioloogilistesse tehiselunditesse kapseldatud rakkude kasvu kontrollimine
PT1077072E (pt) Processo in vitro para produzir uma protese homologa de valvula cardiaca ou uma protese homologa de vaso sanguineo
NL300062I2 (nl) Osteogene middelen.
CO4830493A1 (es) Anticuerpos contra cd40 humano
ES2123910T3 (es) Composiciones que contienen sales anfoteras de alfa-hidroxiacidos y monocaprilato de glicerol.
MY155909A (en) Oral care compositions and methods
DE69837491D1 (de) Menschliche mesenchymale stammzellen aus peripherem blut
BR9910251A (pt) Estimulação hematopoiética
DK1242578T3 (da) Celledyrkningsmedium indeholdende vækstfaktorer og L-glutamin
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
NZ212067A (en) Derivatives of glycerophosphocholine and glycerophosphoethanolamine; preparation and use
IN2012DN02781A (sv)
EP1329461B8 (en) Method of eliminating human serum albumin polymers
BG105275A (en) Tan-1057 derivatives
SE7904161L (sv) Komposition for minskning av fenylalaninnivan i blod och anvendning derav
FR2577048B1 (fr) Reactif pour le dosage par hemagglutination des anticorps contre les toxines bacteriennes, procede de preparation et son application
ES2056651T3 (es) Produccion de una composicion proteinica.
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
DE69929683D1 (de) Antisense modulierung von lfa-3
ES2067058T3 (es) Tratamiento de carnes.
PT795008E (pt) Linhas de celulas de condrocitos hipertroficos humanos
AU2002211063A1 (en) Fluid for haemofiltration
RU95105275A (ru) Применение морской воды, содержащей микроорганизмы класса цианобактерий в качестве заменителя крови
GEU1997160Y (en) Method for Modelling of Sharp Urosepsis

Legal Events

Date Code Title Description
NUG Patent has lapsed